For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| BIA 2-093 3000 mg Once Daily | Subjects in Cohort 2 received a dose of 3000 mg once daily (5 x 600 mg eslicarbazepine acetate tablets) BIA 2-093 3000 mg once daily: Eslicarbazepine acetate 600 mg tablets for oral administration | None | None | 0 | 6 | 6 | 6 | View |
| BIA 2-093 3600 mg Once Daily | Subjects in Cohort 1 received a dose of 3600 mg once daily (6 x 600 mg eslicarbazepine acetate tablets) BIA 2-093 3600 mg once daily: Eslicarbazepine acetate 600 mg tablets for oral administration | None | None | 0 | 6 | 6 | 6 | View |
| Placebo | Matching placebo tablets for oral administration Placebo: Matching placebo tablets for oral administration | None | None | 0 | 4 | 1 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dizziness | None | Nervous system disorders | MedDRA (8.1) | View |
| Somnolence | None | Nervous system disorders | MedDRA (8.1) | View |
| Headache | None | Nervous system disorders | MedDRA (8.1) | View |
| Paraesthesia Oral | None | Nervous system disorders | MedDRA (8.1) | View |
| Paraesthesia | None | Nervous system disorders | MedDRA (8.1) | View |
| Vomiting | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Nausea | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Abdominal Pain | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Abdominal Distension | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Dry Mouth | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Hypoaesthesia Oral | None | Gastrointestinal disorders | MedDRA (8.1) | View |
| Fatigue | None | General disorders | MedDRA (8.1) | View |
| Asthenia | None | General disorders | MedDRA (8.1) | View |
| Vision Blurred | None | Eye disorders | MedDRA (8.1) | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | MedDRA (8.1) | View |